Table 4. Estimated effective doses for typical paediatric CT examinations according to the International Commission on Radiological Protection (ICRP) 60 [13] and ICRP 103 [32] definitions of effective dose.
Examination | Age group | Effective dose (mSv) ICRP 60 | Effective dose (mSv) ICRP 103 |
CT brain | 0–6 months | 2.4 | 1.6 |
6 months to 3 years | 1.9 | 1.3 | |
3–6 years | 1.7 | 1.2 | |
6–10 years | 1.9 | 1.3 | |
>10 years | 1.4 | 1.0 | |
CT chest | <5 years | 1.5 | 1.8 |
5–10 years | 4.6 | 5.6 | |
>10 years | 10 (5.4)a | 13 (6.6)a | |
CT abdomen/pelvis | <5 years | 2.7 | 2.5 |
5–10 years | 6.7 | 6.3 | |
>10 years | 11 (5.1)a | 10 (4.7)a |
aAll values of effective dose have been estimated from the mean DLP16 (dose–length product relative to the 16-cm phantom) values, except those shown in brackets, which have been estimated from the mean DLP32 (dose–length product relative to the 32-cm phantom) values. These have been included for comparison as some of the patients in the >10 years age group will be closer in size to an adult than to a child.